Cargando…

Health-related quality of life of metastatic prostate cancer patients treated with prostate Radiotherapy

BACKGROUND: The impact of prostate radiotherapy on patient-reported health-related quality of life (HRQoL) significantly influences the outcomes of metastatic prostate cancer. We measured and compared HRQoL of metastatic prostate cancer patients who received cytoreductive prostate radiotherapy. METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ayoub, Heba Maged, Zamzam, Maha Lotfy, Elsemary, Eman Essam, Hassanin, Ihab Mohamed, Elsayed, Fifi Mostafa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544568/ https://www.ncbi.nlm.nih.gov/pubmed/37784085 http://dx.doi.org/10.1186/s12885-023-11448-3

Ejemplares similares

Prostate radiotherapy for metastatic hormone sensitive prostate cancer—myth or reality?
por: Onal, Cem
Publicado: (2019)

Treatment results of radiotherapy to both the prostate and metastatic sites in patients with bone metastatic prostate cancer
por: Inaba, Koji, et al.
Publicado: (2021)

Outcome of docetaxel in treatment of metastatic hormone-sensitive prostate cancer and correlation with hemoglobin, albumin, lymphocyte and platelets score
por: Taha, Heba F., et al.
Publicado: (2022)

Quality of life in patients with prostate cancer treated with radical image-guided radiotherapy
por: Majewski, Wojciech, et al.
Publicado: (2014)

Bone lesion absorbed dose profiles in patients with metastatic prostate cancer treated with molecular radiotherapy
por: Denis-Bacelar, Ana M, et al.
Publicado: (2018)

The application of the Glasgow prognostic score to predict the survival in patients with metastatic pancreatic carcinoma
por: Mohammed, Amrallah A., et al.
Publicado: (2022)

Metastatic Spread in Prostate Cancer Patients Influencing Radiotherapy Response
por: Klusa, Daria, et al.
Publicado: (2021)

Interaction Between Modern Radiotherapy and Immunotherapy for Metastatic Prostate Cancer
por: Ollivier, Luc, et al.
Publicado: (2021)

Clinical outcome in metastatic prostate cancer after primary radiotherapy
por: Moll, Matthias, et al.
Publicado: (2022)

Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis
por: Burdett, Sarah, et al.
Publicado: (2019)

Survival in Patients With Metastatic Prostate Cancer Undergoing Radiotherapy: The Importance of Prostate-Specific Antigen-Based Stratification
por: Tian, Zijian, et al.
Publicado: (2021)

Cutaneous metastasis of prostate carcinoma treated with electron radiotherapy
por: Arase, Shigeki, et al.
Publicado: (2019)

Prediction of Survival Outcome Using Chuang's Prognostic Scale in Metastatic Breast Cancer
por: Mohammed, Amrallah A, et al.
Publicado: (2021)

WHO SHOULD RECEIVE RADIOTHERAPY IN METASTATIC HORMONE-SENSITIVE PROSTATE CANCER?
por: Bišof, Vesna
Publicado: (2019)

Large Prostate Volume Does Not Negatively Impact Health-Related Quality of Life in Patients with Prostate Cancer Treated with Ultrahypofractionated Stereotactic Body Radiotherapy
por: Milecki, Piotr, et al.
Publicado: (2023)

Normalization of prostate specific antigen in patients treated with intensity modulated radiotherapy for clinically localized prostate cancer
por: Schmitz, Matthew D, et al.
Publicado: (2010)

Survival advantage of Asian metastatic prostate cancer patients treated with external beam radiotherapy over other races/ethnicities
por: Würnschimmel, Christoph, et al.
Publicado: (2021)

Type and dose of radiotherapy used for initial treatment of non-metastatic prostate cancer
por: Wang, Dian, et al.
Publicado: (2014)

Local and metastatic curative radiotherapy in patients with de novo oligometastatic prostate cancer
por: Reverberi, C., et al.
Publicado: (2020)

Androgen Receptor Targeted Therapy + Radiotherapy in Metastatic Castration Resistant Prostate Cancer
por: Massaro, Maria, et al.
Publicado: (2021)

Inhibition of CXCR4 Enhances the Efficacy of Radiotherapy in Metastatic Prostate Cancer Models
por: Gupta, Nisha, et al.
Publicado: (2023)

Tuberculous prostatitis mimicking metastatic prostate cancer
por: Aslan, Serdar, et al.
Publicado: (2022)

Aggressive Care at the End of Life; Where Are We?
por: Mohammed, Amrallah A, et al.
Publicado: (2019)

Metastatic hormone-sensitive prostate cancer: How should it be treated?
por: López-Campos, Fernando, et al.
Publicado: (2021)

Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial
por: Parker, Chris C., et al.
Publicado: (2022)

Metastatic Breast Carcinoma to the Prostate Gland
por: Kapp, Meghan E., et al.
Publicado: (2016)

Cutaneous metastasis of prostate carcinoma treated with radiotherapy: a case presentation
por: Mak, Gabriel, et al.
Publicado: (2014)

Salvage brachytherapy for local recurrences of prostate cancer treated previously with radiotherapy
por: Gawkowska-Suwinska, Marzena, et al.
Publicado: (2010)

Inguinal hernia in a patient with prostate cancer to be treated with photon radiotherapy
por: Oike, Takahiro, et al.
Publicado: (2020)

Impact of age on treatment response in men with prostate cancer treated with radiotherapy
por: Bryant, Alex K., et al.
Publicado: (2021)

Radiotherapy Induces Innate Immune Responses in Patients Treated for Prostate Cancers
por: Cheema, Amrita K., et al.
Publicado: (2023)

Hypofractionated radiotherapy for prostate cancer
por: Hegemann, Nina-Sophie, et al.
Publicado: (2014)

Impact of Time to Castration Resistance on Cytoreductive Radiotherapy in Metastatic Castration-Resistant Prostate Cancer
por: Mai, Lixin, et al.
Publicado: (2020)

Radiotherapy to the Primary Tumor: The First Step of a Tailored Therapy in Metastatic Prostate Cancer
por: Ferro, Matteo, et al.
Publicado: (2022)

RADIOTHERAPY OF PROSTATE CANCER: PRIMARY RADIOTHERAPY AND RADIOTHERAPY IN DISEASE RELAPSE
por: Antunac, Katarina
Publicado: (2019)

Health-related quality of life in men with localized prostate cancer treated with radiotherapy: validation of an abbreviated version of the Expanded Prostate Cancer Index Composite for Clinical Practice in Spain
por: Zapatero, Almudena, et al.
Publicado: (2021)

Pembrolizumab in men with heavily treated metastatic castrate‐resistant prostate cancer
por: Tucker, Matthew D., et al.
Publicado: (2019)

Fracture Risk in Men with Metastatic Prostate Cancer Treated With Radium-223
por: Hijab, Adham, et al.
Publicado: (2021)

Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy
por: Gill, Suki, et al.
Publicado: (2011)

Outcomes and predictors of localized or locally-advanced prostate cancer treated by radiotherapy in Indonesia
por: Supit, Wempy, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_gbdf8dk1ah4s7jmqon0il1j3pu